AbbVie (ABBV) call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics (APGE), FT reports
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $255.96 +1.05%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: +24.9%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: +24.9%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) 30-day call option implied volatility 26; compared to its 52-week range of 18 to 36. Call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics, FT reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- U.S. to begin rulemaking aimed at shoring up car door safety - Bloomberg
- Deckers Brands (DECK) call put ratio 1 call to 4.9 puts with a focus on July 24 weekly puts into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Definitive Agreement, Maynard Um, Mark Zuckerberg, ARK, apgeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
